Olanzapine Pamoate — Active Pharmaceutical Ingredient

Olanzapine Pamoate is an active pharmaceutical ingredient found in 1 FDA-approved drug product. Forms: SUSPENSION, EXTENDED RELEASE. Routes: INTRAMUSCULAR.

Drug Ingredients A–Z 1 min read
This content is for informational purposes only. Always consult a healthcare professional.

Olanzapine Pamoate (1 brand name, 1 dosage form, 1 route)

Available dosage forms: SUSPENSION, EXTENDED RELEASE.

Routes of administration: INTRAMUSCULAR.

Brand Names

  • ZYPREXA RELPREVV

Indications and Usage

ZYPREXA RELPREVV is available only through a restricted distribution program [see Warnings and Precautions (5.2)]. ZYPREXA RELPREVV must not be dispensed directly to a patient. For a patient to receive treatment, the prescriber, healthcare setting, patient, and pharmacy must all be enrolled in the ZYPREXA RELPREVV REMS. To enroll, call 1-877-772-9390.

Contraindications

None.

Mechanism of Action

The mechanism of action of olanzapine, in the listed indications is unclear. However, the efficacy of olanzapine in schizophrenia could be mediated through a combination of dopamine and serotonin type 2 (5HT2) antagonism.

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.